SCHEMBL14524451

SCHEMBL14524451

C=CC(=O)Nc1ccccc1N=N

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TGM2 P21980 9/20 0.50
▸ PTPN1 P18031 1/20 0.45
▸ PTPN11 Q06124 1/20 0.45
▸ F13A1 P00488 1/20 0.40
▸ LMNA P02545 1/20 0.40
▸ TGM1 P22735 1/20 0.40
▸ TGM3 Q08188 1/20 0.40
▸ BTK Q06187 2/20 0.39
▸ EGFR P00533 1/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ MAPT P10636 1/20 0.38
▸ PKM P14618 1/20 0.38
▸ GSTO1 P78417 2/20 0.37
▸ RORC P51449 1/20 0.37
▸ TEC P42680 1/20 0.36
▸ TXK P42681 1/20 0.36
▸ BMX P51813 1/20 0.36
▸ JAK3 P52333 1/20 0.36
▸ ITK Q08881 1/20 0.36
▸ ERBB4 Q15303 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14690416 0.86 TGM2 (0.53) TGM2PTPN1PTPN11F13A1LMNA
SCHEMBL13074221 0.84 TGM2 (0.52) TGM2PTPN1PTPN11F13A1LMNA
SCHEMBL31228347 0.81 TGM2 (0.65) TGM2PTPN1PTPN11F13A1LMNA
SCHEMBL613090 0.81 TGM2 (0.65) TGM2PTPN1PTPN11F13A1LMNA
SCHEMBL9702270 0.80 TGM2 (0.47) TGM2PTPN1PTPN11F13A1LMNA
SCHEMBL5183351 0.79 TGM2 (0.50) TGM2PTPN1PTPN11LMNAEGFR
SCHEMBL11883844 0.77 TGM2 (0.55) TGM2PTPN1PTPN11F13A1LMNA
SCHEMBL8243220 0.77 NPC1 (0.36) KDM4EMAPT
SCHEMBL14690089 0.75 TGM2 (0.54) TGM2PTPN1PTPN11F13A1LMNA
SCHEMBL2761954 0.74 TGM2 (0.62) TGM2PTPN1PTPN11F13A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007072521-A1 POLYMER STRUCTURE REACTING WITH KERATIN, SYNTHESIS AND USE THEREOF EUDERMIC S.R.L. (IT) 2007-06-28 — — WO disclosed
Send feedback